Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B3CC
|
|||
| Former ID |
DNCL002493
|
|||
| Drug Name |
AlloStim
|
|||
| Synonyms |
AlloStim (TN)
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2/3 | [1] | |
| Metastatic colorectal cancer [ICD-11: 2B91; ICD-10: C19] | Phase 2 | [2], [3], [4] | ||
| Company |
Immunovative Therapies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01741038) Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.